Effect of a Probiotic Formula on Reducing SIBO in IBS Patients

NCT04316806 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Principal Investigator changed his job

Conditions

Irritable Bowel Syndrome
Small Intestinal Bacterial Overgrowth

Interventions

DIETARY_SUPPLEMENT: Probiotic
DRUG: Rifaximin

Sponsor

AB Biotics, SA